Mode
Text Size
Log in / Sign up

CDC panel recommends PRIORIX vaccine for measles, mumps, and rubella protection

Share
CDC panel recommends PRIORIX vaccine for measles, mumps, and rubella protection
Photo by Navy Medicine / Unsplash

A committee that advises the Centers for Disease Control and Prevention (CDC) has made a formal recommendation for using the PRIORIX vaccine. PRIORIX protects against three diseases: measles, mumps, and rubella. This recommendation means doctors in the United States can now use PRIORIX as another option alongside the familiar MMR vaccine.

The announcement did not include specific details about the studies that led to this decision. We don't know how many people were in the studies, what specific results were found, or if there were any notable side effects. This is common for official recommendations, which often summarize conclusions without publishing all the underlying data at the same time.

It's important to understand that this is a recommendation for use, not a report on new research findings. The recommendation likely came from reviewing existing data that showed PRIORIX works safely and well. For patients and parents, this simply means there is now a second approved vaccine option for protection against these three viruses. You should talk with your doctor about which vaccine is right for you or your child.

What this means for you:
A second MMR vaccine is now recommended for use in the US. Talk to your doctor about your options.
Share
More on Measles